VANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vantin, and when can generic versions of Vantin launch?
Vantin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in VANTIN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vantin
A generic version of VANTIN was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
Summary for VANTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Clinical Trials: | 2 |
Patent Applications: | 2,093 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VANTIN at DailyMed |
Recent Clinical Trials for VANTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington University School of Medicine | N/A |
University of Oklahoma | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for VANTIN
US Patents and Regulatory Information for VANTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050675-001 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | TABLET;ORAL | 050674-002 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050675-002 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |